Fliar explore / investors

Biopharmaceuticals investors in the United States.

Fliar publishes 47 investor pages for Biopharmaceuticals in the United States. That is 45 investor lists and 2 angel lists. The list with the most capital behind it is Biopharmaceuticals investors in Cambridge ($218.4B across the rounds it covers).

In this directory47investor pages

47 pages

Investor listBiopharmaceuticals investors in CambridgeBiopharmaceuticals · Cambridge, United States904 investors307 companies$218.4B in roundsInvestor listBiopharmaceuticals investors in San FranciscoBiopharmaceuticals · San Francisco, United States785 investors208 companies$133.9B in roundsInvestor listBiopharmaceuticals investors in San DiegoBiopharmaceuticals · San Diego, United States680 investors215 companies$122.9B in roundsInvestor listBiopharmaceuticals investors in BostonBiopharmaceuticals · Boston, United States416 investors109 companies$76B in roundsInvestor listBiopharmaceuticals investors in SeattleBiopharmaceuticals · Seattle, United States276 investors56 companies$41.3B in roundsInvestor listBiopharmaceuticals investors in WalthamBiopharmaceuticals · Waltham, United States219 investors34 companies$40.5B in roundsInvestor listBiopharmaceuticals investors in New York CityBiopharmaceuticals · New York City, United States313 investors103 companies$37.9B in roundsInvestor listBiopharmaceuticals investors in Redwood CityBiopharmaceuticals · Redwood City, United States153 investors27 companies$23.6B in roundsInvestor listBiopharmaceuticals investors in Menlo ParkBiopharmaceuticals · Menlo Park, United States200 investors29 companies$22.7B in roundsInvestor listBiopharmaceuticals investors in WatertownBiopharmaceuticals · Watertown, United States127 investors22 companies$21.9B in roundsInvestor listBiopharmaceuticals investors in PhiladelphiaBiopharmaceuticals · Philadelphia, United States182 investors39 companies$18.9B in roundsInvestor listBiopharmaceuticals investors in San MateoBiopharmaceuticals · San Mateo, United States117 investors19 companies$15.5B in roundsInvestor listBiopharmaceuticals investors in DurhamBiopharmaceuticals · Durham, United States138 investors30 companies$14.3B in roundsInvestor listBiopharmaceuticals investors in BoulderBiopharmaceuticals · Boulder, United States113 investors11 companies$12.4B in roundsInvestor listBiopharmaceuticals investors in Palo AltoBiopharmaceuticals · Palo Alto, United States129 investors29 companies$12.1B in roundsInvestor listBiopharmaceuticals investors in BerkeleyBiopharmaceuticals · Berkeley, United States130 investors21 companies$11.6B in roundsInvestor listBiopharmaceuticals investors in LexingtonBiopharmaceuticals · Lexington, United States152 investors26 companies$11.4B in roundsInvestor listBiopharmaceuticals investors in Los AngelesBiopharmaceuticals · Los Angeles, United States72 investors21 companies$10.4B in roundsInvestor listBiopharmaceuticals investors in San CarlosBiopharmaceuticals · San Carlos, United States125 investors22 companies$8.5B in roundsInvestor listBiopharmaceuticals investors in NewtonBiopharmaceuticals · Newton, United States57 investors10 companies$8.4B in roundsInvestor listBiopharmaceuticals investors in EmeryvilleBiopharmaceuticals · Emeryville, United States80 investors10 companies$7.6B in roundsInvestor listBiopharmaceuticals investors in RockvilleBiopharmaceuticals · Rockville, United States95 investors20 companies$6.8B in roundsInvestor listBiopharmaceuticals investors in New HavenBiopharmaceuticals · New Haven, United States82 investors19 companies$5.7B in roundsInvestor listBiopharmaceuticals investors in GaithersburgBiopharmaceuticals · Gaithersburg, United States82 investors18 companies$5.3B in roundsInvestor listBiopharmaceuticals investors in Mountain ViewBiopharmaceuticals · Mountain View, United States63 investors10 companies$5.2B in roundsInvestor listBiopharmaceuticals investors in MalvernBiopharmaceuticals · Malvern, United States90 investors17 companies$5B in roundsInvestor listBiopharmaceuticals investors in DallasBiopharmaceuticals · Dallas, United States54 investors10 companies$4.9B in roundsInvestor listBiopharmaceuticals investors in IrvineBiopharmaceuticals · Irvine, United States63 investors16 companies$4.6B in roundsInvestor listBiopharmaceuticals investors in HaywardBiopharmaceuticals · Hayward, United States64 investors10 companies$4.5B in roundsInvestor listBiopharmaceuticals investors in CincinnatiBiopharmaceuticals · Cincinnati, United States35 investors8 companies$3.7B in roundsInvestor listBiopharmaceuticals investors in HoustonBiopharmaceuticals · Houston, United States92 investors32 companies$3.6B in roundsInvestor listBiopharmaceuticals investors in PrincetonBiopharmaceuticals · Princeton, United States84 investors17 companies$3.5B in roundsInvestor listBiopharmaceuticals investors in AustinBiopharmaceuticals · Austin, United States71 investors18 companies$3.4B in roundsInvestor listBiopharmaceuticals investors in Ann ArborBiopharmaceuticals · Ann Arbor, United States62 investors8 companies$3B in roundsInvestor listBiopharmaceuticals investors in BurlingameBiopharmaceuticals · Burlingame, United States46 investors11 companies$2.9B in roundsInvestor listBiopharmaceuticals investors in ChicagoBiopharmaceuticals · Chicago, United States43 investors10 companies$2.6B in roundsInvestor listBiopharmaceuticals investors in St. LouisBiopharmaceuticals · St. Louis, United States28 investors9 companies$2.3B in roundsInvestor listBiopharmaceuticals investors in ColumbusBiopharmaceuticals · Columbus, United States42 investors9 companies$2.3B in roundsInvestor listBiopharmaceuticals investors in PittsburghBiopharmaceuticals · Pittsburgh, United States64 investors16 companies$2.1B in roundsInvestor listBiopharmaceuticals investors in Chapel HillBiopharmaceuticals · Chapel Hill, United States44 investors11 companies$1.8B in roundsAngel listBiopharmaceuticals angel investors in CambridgeBiopharmaceuticals · Cambridge, United States29 investors29 companies$1.5B in roundsInvestor listBiopharmaceuticals investors in SunnyvaleBiopharmaceuticals · Sunnyvale, United States41 investors9 companies$1.3B in roundsInvestor listBiopharmaceuticals investors in BaltimoreBiopharmaceuticals · Baltimore, United States67 investors23 companies$1.1B in roundsAngel listBiopharmaceuticals angel investors in San FranciscoBiopharmaceuticals · San Francisco, United States42 investors16 companies$726.3M in roundsInvestor listBiopharmaceuticals investors in ClevelandBiopharmaceuticals · Cleveland, United States37 investors8 companies$687.4M in roundsInvestor listBiopharmaceuticals investors in Salt Lake CityBiopharmaceuticals · Salt Lake City, United States22 investors8 companies$337.9M in roundsInvestor listBiopharmaceuticals investors in IndianapolisBiopharmaceuticals · Indianapolis, United States12 investors9 companies$80.8M in rounds
About this directory page

Biopharmaceuticals investors in the United States

Fliar publishes 47 investor pages for Biopharmaceuticals in the United States. That is 45 investor lists and 2 angel lists. The list with the most capital behind it is Biopharmaceuticals investors in Cambridge ($218.4B across the rounds it covers).

These are all the Biopharmaceuticals investors in the United States we publish. For a wider view, see all Biopharmaceuticals investor pages or everything in the United States.

Close neighbours of Biopharmaceuticals are Life Sciences, Oncology, HealthTech, Artificial Intelligence, Medical Devices and Cybersecurity.

Keep browsing across Fliar: Biopharmaceuticals company lists in the United States (1).

Same market, other page types
All sectors in United States A–Z 693
All locations for Biopharmaceuticals A–Z 117